$0.23 EPS Expected for Global Medical REIT Inc (GMRE) This Quarter

Brokerages predict that Global Medical REIT Inc (NYSE:GMRE) will report $0.23 earnings per share for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Global Medical REIT’s earnings. The highest EPS estimate is $0.25 and the lowest is $0.21. Global Medical REIT reported earnings per share of $0.17 during the same quarter last year, which would indicate a positive year over year growth rate of 35.3%. The firm is scheduled to issue its next quarterly earnings report after the market closes on Monday, November 5th.

On average, analysts expect that Global Medical REIT will report full year earnings of $0.82 per share for the current year, with EPS estimates ranging from $0.78 to $0.89. For the next fiscal year, analysts anticipate that the company will post earnings of $0.92 per share, with EPS estimates ranging from $0.86 to $1.00. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that cover Global Medical REIT.

Global Medical REIT (NYSE:GMRE) last announced its quarterly earnings results on Tuesday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.01). The firm had revenue of $13.25 million during the quarter, compared to the consensus estimate of $12.86 million. Global Medical REIT had a return on equity of 1.91% and a net margin of 8.00%.

A number of equities research analysts have issued reports on GMRE shares. Zacks Investment Research lowered shares of Global Medical REIT from a “buy” rating to a “hold” rating in a report on Wednesday, July 25th. Boenning Scattergood reissued a “hold” rating on shares of Global Medical REIT in a report on Thursday, August 9th. Robert W. Baird started coverage on shares of Global Medical REIT in a report on Thursday, October 11th. They issued an “outperform” rating and a $11.00 price target on the stock. Finally, B. Riley set a $11.00 price target on shares of Global Medical REIT and gave the stock a “buy” rating in a report on Friday, August 10th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Global Medical REIT presently has an average rating of “Buy” and an average price target of $10.40.

Global Medical REIT stock traded down $0.01 during trading hours on Tuesday, reaching $9.10. The stock had a trading volume of 81,307 shares, compared to its average volume of 60,744. The firm has a market cap of $196.84 million, a PE ratio of 16.85, a price-to-earnings-growth ratio of 1.23 and a beta of 0.51. Global Medical REIT has a 52 week low of $6.34 and a 52 week high of $10.05. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 1.63.

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 10th. Shareholders of record on Thursday, September 20th were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 8.79%. The ex-dividend date was Wednesday, September 19th. Global Medical REIT’s dividend payout ratio (DPR) is presently 148.15%.

Institutional investors and hedge funds have recently made changes to their positions in the company. Citadel Advisors LLC bought a new stake in shares of Global Medical REIT during the 2nd quarter valued at about $194,000. A.R.T. Advisors LLC boosted its stake in shares of Global Medical REIT by 126.4% during the 1st quarter. A.R.T. Advisors LLC now owns 28,130 shares of the company’s stock valued at $195,000 after purchasing an additional 15,703 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Global Medical REIT during the 1st quarter valued at about $224,000. Schwab Charles Investment Management Inc. boosted its stake in shares of Global Medical REIT by 32.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 37,600 shares of the company’s stock valued at $334,000 after purchasing an additional 9,200 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Global Medical REIT by 77.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 57,936 shares of the company’s stock valued at $403,000 after purchasing an additional 25,321 shares in the last quarter. 42.06% of the stock is currently owned by hedge funds and other institutional investors.

About Global Medical REIT

Global Medical REIT, Inc operates as a development stage company that intends to develop and manage a portfolio of healthcare real estate assets and properties. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Featured Story: Find a Trading Strategy That Works

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply